Dr. Zheng has 25 years of broad experience in biotech industry to develop therapeutic proteins, antibody drugs and vaccines in USA and China. His expertise spans from process development, technology transfer to cGMP production. He is a CMC leader with experience to develop both biosimilar and innovator drugs, and has brought multiple biologic products to market.

Previously Dr. Zheng is the co-founder and VP of DZM Biotech and VP of Jecho Biopharma. Before returning back to China 10 years ago, he held several technical and management positions as principal scientist and project manager in MedImmune, Wyeth, Pfizer with increased responsibilities.

Dr. Zheng received his bachelor degree in chemistry from Beijing Normal University, Ph.D. in chemistry from Nankai University, and did his postdoctoral training in Department of Chemistry, Aarhus University, Denmark and Department of Chemistry and Biochemistry, University of Delaware, USA.

Mr. Luo gained more than 30 years of quality operation and management experience in the pharmaceutical / biotechnology industry.  He has comprehensive knowledge and experience in handling daily quality issues and systematically developing quality management tools and procedures, especially in setting up the phase appropriate GMP systems. He successfully led the company through the regulatory pre-approval inspection (PAI) for commercial drug productions. Mr. Luo is an accomplished quality executive that skilled in the development, implementation and execution of quality systems.

Before joining Chime Biologics, Mr. Luo worked for Eli Lilly (USA), Amgen (USA), WuXi Biologics, Livzonmab, Mabplex and other well-known international and domestic biopharmaceutical companies and held various important positions in quality management.

Mr. Luo received a bachelor’s degree in Chemistry from Nanjing University in 1982, a master’s degree in Chemistry from University of Louisville in 1995 and an MBA from Kelley School of Business from Indiana University in 2004.

Mr. Chen has over 20 years’ experience in biomedical research, marketing, business, project management, capital raising, corporate senior management and operations. Before joining Chime Biologics, he served as General Manager, Senior Vice President and Marketing Director of Wuhan Optics Valley New Drug Incubation Public Service Platform Co., LTD., and also worked in Vital Pharmaceutical as Marketing Manager, R&D supervisor and other management positions. He is familiar with company operation and capital operation, and has rich experience in team building and business cooperation negotiation.

Mr. Chen obtained a Master degree in Microbiology and Biochemistry from Wuhan University.